Thoroughbred Financial Services LLC Has $5.35 Million Stock Position in UnitedHealth Group Incorporated (NYSE:UNH)

Thoroughbred Financial Services LLC decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH - Free Report) by 16.2% during the 1st quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The firm owned 10,215 shares of the healthcare conglomerate's stock after selling 1,970 shares during the quarter. Thoroughbred Financial Services LLC's holdings in UnitedHealth Group were worth $5,350,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors also recently modified their holdings of UNH. Accent Capital Management LLC increased its stake in UnitedHealth Group by 10.6% in the first quarter. Accent Capital Management LLC now owns 6,465 shares of the healthcare conglomerate's stock valued at $3,386,000 after purchasing an additional 622 shares in the last quarter. Empire Life Investments Inc. grew its holdings in shares of UnitedHealth Group by 1.9% in the 1st quarter. Empire Life Investments Inc. now owns 12,322 shares of the healthcare conglomerate's stock valued at $6,454,000 after buying an additional 227 shares during the period. ING Groep NV raised its stake in UnitedHealth Group by 4.2% during the 1st quarter. ING Groep NV now owns 122,145 shares of the healthcare conglomerate's stock worth $63,973,000 after buying an additional 4,871 shares during the period. Earned Wealth Advisors LLC acquired a new position in UnitedHealth Group in the first quarter valued at about $586,000. Finally, SGL Investment Advisors Inc. lifted its holdings in shares of UnitedHealth Group by 7.5% during the 1st quarter. SGL Investment Advisors Inc. now owns 1,900 shares of the healthcare conglomerate's stock valued at $995,000 after purchasing an additional 133 shares in the last quarter. 87.86% of the stock is currently owned by institutional investors and hedge funds.

Analyst Ratings Changes

UNH has been the topic of several research analyst reports. JPMorgan Chase & Co. raised their target price on shares of UnitedHealth Group from $405.00 to $418.00 and gave the stock an "overweight" rating in a report on Friday, June 20th. KeyCorp reduced their target price on shares of UnitedHealth Group from $400.00 to $350.00 and set an "overweight" rating for the company in a research note on Wednesday, July 30th. Royal Bank Of Canada cut their price target on UnitedHealth Group from $355.00 to $286.00 and set an "outperform" rating on the stock in a report on Wednesday, July 30th. Argus downgraded UnitedHealth Group from a "buy" rating to a "hold" rating in a report on Monday, April 21st. Finally, Wells Fargo & Company dropped their target price on shares of UnitedHealth Group from $306.00 to $267.00 and set an "overweight" rating on the stock in a report on Monday. Three analysts have rated the stock with a sell rating, seven have issued a hold rating and fifteen have issued a buy rating to the company's stock. According to data from MarketBeat, UnitedHealth Group has a consensus rating of "Hold" and an average target price of $371.67.

UnitedHealth Group Stock Up 1.3%

UNH stock opened at $240.94 on Tuesday. The company has a market cap of $218.57 billion, a PE ratio of 10.44, a price-to-earnings-growth ratio of 1.50 and a beta of 0.43. The company has a quick ratio of 0.85, a current ratio of 0.85 and a debt-to-equity ratio of 0.73. UnitedHealth Group Incorporated has a 52 week low of $234.60 and a 52 week high of $630.73. The business has a 50-day simple moving average of $295.77 and a 200 day simple moving average of $412.81.

UnitedHealth Group (NYSE:UNH - Get Free Report) last posted its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing the consensus estimate of $4.45 by ($0.37). UnitedHealth Group had a return on equity of 23.32% and a net margin of 5.04%. The firm had revenue of $111.62 billion for the quarter, compared to analyst estimates of $111.75 billion. During the same quarter in the prior year, the business posted $6.80 EPS. The business's revenue was up 12.9% on a year-over-year basis. Sell-side analysts anticipate that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Increases Dividend

The firm also recently announced a quarterly dividend, which was paid on Tuesday, June 24th. Shareholders of record on Monday, June 16th were paid a dividend of $2.21 per share. The ex-dividend date of this dividend was Monday, June 16th. This is a positive change from UnitedHealth Group's previous quarterly dividend of $2.10. This represents a $8.84 annualized dividend and a yield of 3.7%. UnitedHealth Group's payout ratio is presently 38.30%.

Insider Transactions at UnitedHealth Group

In related news, Director Timothy Patrick Flynn purchased 1,533 shares of the firm's stock in a transaction that occurred on Wednesday, May 14th. The shares were bought at an average cost of $320.80 per share, with a total value of $491,786.40. Following the acquisition, the director owned 6,033 shares of the company's stock, valued at $1,935,386.40. This trade represents a 34.07% increase in their position. The transaction was disclosed in a legal filing with the SEC, which is available through this hyperlink. Also, CFO John F. Rex bought 17,175 shares of the business's stock in a transaction on Friday, May 16th. The stock was bought at an average price of $291.12 per share, for a total transaction of $4,999,986.00. Following the transaction, the chief financial officer directly owned 203,796 shares of the company's stock, valued at approximately $59,329,091.52. This represents a 9.20% increase in their ownership of the stock. The disclosure for this purchase can be found here. In the last three months, insiders have purchased 109,408 shares of company stock valued at $31,607,768. 0.28% of the stock is owned by company insiders.

UnitedHealth Group Company Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.